Skip to content
Annalist
Companies Atlas Screener Compare Deal Lab For AI agents Data Quality Method

Atlas

Merck & Co., Inc.

US · LEI 4YV9Y5M8S0BRK1RP0397 · Figures of the company

Merck & Co., Inc.: 11 links from the documents of the companies and the register.

Holdings 1

EntityFigureEvidenceDocuments
Merck Sharp & Dohme LLCConsolidates the entityRegisterRecord of Merck Sharp & Dohme LLC in the register of legal entities, 4 November 2026

Partners 10

EntityFigureEvidenceDocuments
AstraZeneca PLCCollaboration revenue of $1.9bn, fiscal year ended 31 Dec 2025StatedForm 10-K for the fiscal year ended 31 December 2025
Eisai Co., Ltd.Collaboration revenue of $1.1bn, fiscal year ended 31 Dec 2025StatedForm 10-K for the fiscal year ended 31 December 2025
Bayer AGCollaboration revenue of $830m, fiscal year ended 31 Dec 2025StatedForm 10-K for the fiscal year ended 31 December 2025
Bristol-Myers Squibb CompanyCollaboration revenue of $525m, fiscal year ended 31 Dec 2025StatedForm 10-K for the fiscal year ended 31 December 2025
Alteogen Inc.Named as a collaboration partnerStatedForm 10-K for the fiscal year ended 31 December 2025
Daiichi Sankyo Company, LimitedNamed as a collaboration partnerStatedForm 10-K for the fiscal year ended 31 December 2025
Moderna, Inc.Named as a collaboration partnerStatedForm 10-K for the fiscal year ended 31 December 2025
Orion CorporationNamed as a collaboration partnerStatedForm 10-K for the fiscal year ended 31 December 2025
Ridgeback Biotherapeutics LPNamed as a collaboration partnerStatedForm 10-K for the fiscal year ended 31 December 2025
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.Named as a collaboration partnerStatedForm 10-K for the fiscal year ended 31 December 2025

Each link names the documents that state it, with the class of its evidence: stated by one party, confirmed by both, or stated by the register of legal entities. A commitment is the commitment at the date of the agreement.